Basic Information
Novaremed AG is a Swiss biopharmaceutical company in the clinical research stage, dedicated to the development of NRD.E1, an orally active new chemical entity (NCE) for the treatment of neuropathic pain.
Novaremed AG
Basel,CantonofBasel-City,Switzerland
less than 15 people
January 01, 2017
--
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios